Viral eye infections can significantly impact eye comfort, visual clarity, and overall ocular health. Conditions such as viral keratitis, particularly those caused by the herpes simplex virus (HSV), require prompt and effective treatment to prevent complications and support healing. CIPVISION GIVOSIRUN, formulated with Ganciclovir Ophthalmic Gel 0.15% w/w, is an advanced antiviral ophthalmic treatment designed to help manage specific viral eye infections under the guidance of an eye care professional.

With its targeted antiviral action and convenient gel formulation, CIPVISION GIVOSIRUN provides prolonged contact time with the ocular surface, helping deliver effective therapy directly where it is needed.

What is CIPVISION GIVOSIRUN?

CIPVISION GIVOSIRUN is a sterile ophthalmic gel containing Ganciclovir 0.15% w/w, an antiviral agent widely used in ophthalmology for the treatment of certain viral infections affecting the cornea and ocular surface.

The gel formulation is specifically designed to:

• Deliver sustained antiviral activity
• Increase ocular surface contact time
• Support healing of viral corneal lesions
• Improve patient comfort during treatment

CIPVISION GIVOSIRUN is commonly prescribed by ophthalmologists for the treatment of herpes simplex viral keratitis and other selected ocular viral infections.

Composition

Active Ingredient:

Ganciclovir Ophthalmic Gel 0.15% w/w

Ganciclovir is a potent antiviral medication that inhibits viral DNA replication, helping prevent the spread and multiplication of susceptible viruses.

How CIPVISION GIVOSIRUN Works

Ganciclovir works by interfering with the replication process of certain viruses, particularly herpes simplex virus (HSV), which is a common cause of viral keratitis.

Mechanism of Action

• Inhibits viral DNA synthesis
• Prevents replication of infected viral cells
• Limits the spread of infection
• Supports corneal healing
• Helps reduce viral load within ocular tissues

By targeting the virus directly, CIPVISION GIVOSIRUN helps control infection while promoting recovery of the affected eye tissues.

What is Viral Keratitis?

Viral keratitis is an infection of the cornea, often caused by the Herpes Simplex Virus (HSV). The cornea is the transparent front surface of the eye that plays a crucial role in vision.

When infected, patients may experience:

• Eye redness
• Excessive tearing
• Eye pain
• Foreign body sensation
• Blurred vision
• Light sensitivity (photophobia)
• Corneal lesions

Without appropriate treatment, viral keratitis may lead to corneal scarring and vision complications.

Benefits of CIPVISION GIVOSIRUN

Effective Antiviral Activity

Ganciclovir provides targeted antiviral action against susceptible viruses affecting the eye.

Prolonged Ocular Surface Contact

The gel formulation remains on the ocular surface longer than standard eye drops, enhancing therapeutic effectiveness.

Supports Corneal Healing

Helps manage viral replication while allowing the corneal tissue to recover.

Reduces Infection Progression

Early treatment may help limit the spread and severity of viral infection.

Convenient Ophthalmic Gel Formulation

Provides sustained delivery and improved retention on the eye surface.

Indications of CIPVISION GIVOSIRUN

CIPVISION GIVOSIRUN may be prescribed for:

Herpes Simplex Keratitis

A viral corneal infection caused by herpes simplex virus.

Dendritic Corneal Ulcers

Characteristic branching lesions often associated with HSV keratitis.

Superficial Viral Corneal Infections

Selected viral infections involving the ocular surface as determined by an ophthalmologist.

Management of Ocular Viral Conditions

Where antiviral therapy is clinically indicated.

Why Early Treatment is Important

Timely treatment of viral eye infections is essential because delayed intervention can increase the risk of:

• Corneal scarring
• Recurrent infections
• Persistent inflammation
• Vision impairment
• Long-term ocular complications

Early diagnosis and appropriate antiviral therapy can significantly improve treatment outcomes.

Advantages of Ganciclovir Ophthalmic Gel

Ganciclovir has become a preferred antiviral treatment in ophthalmology due to several advantages:

Targeted Viral Control

Acts directly on viral replication processes.

Minimal Systemic Exposure

Localized ophthalmic application focuses treatment where needed.

Enhanced Patient Comfort

Gel formulation reduces frequent application requirements in many treatment protocols.

Proven Clinical Utility

Widely used for managing herpes simplex ocular infections.

Improved Ocular Retention

Remains in contact with infected tissues longer than conventional solutions.

Who May Benefit from CIPVISION GIVOSIRUN?

CIPVISION GIVOSIRUN may be recommended for:

Patients with Herpes Simplex Keratitis

Individuals diagnosed with HSV-related corneal infections.

Patients Experiencing Recurrent Ocular Viral Infections

Where antiviral management is necessary.

Individuals with Viral Corneal Lesions

Patients requiring targeted antiviral ophthalmic therapy.

Patients Under Specialist Eye Care

Those receiving treatment from ophthalmologists for viral ocular conditions.

Directions for Use

1. Wash your hands thoroughly before use.
2. Open the tube carefully without touching the tip.
3. Tilt your head backward.
4. Pull down the lower eyelid gently.
5. Apply the prescribed amount of gel into the conjunctival sac.
6. Close your eye gently for a few moments.
7. Avoid touching the tube tip to the eye or any surface.
8. Recap the tube securely after use.

Always use CIPVISION GIVOSIRUN exactly as prescribed by your ophthalmologist.

Safety and Precautions

To ensure optimal treatment outcomes:

• Use only under medical supervision.
• Do not discontinue treatment prematurely.
• Avoid touching the applicator tip.
• Inform your doctor about any existing eye conditions.
• Attend scheduled follow-up examinations.
• Follow dosage instructions carefully.

Proper compliance helps maximize treatment effectiveness.

Maintaining Healthy Eyes During Recovery

Practice Good Hygiene

Wash hands before and after touching the eyes.

Avoid Eye Rubbing

Rubbing may worsen irritation and delay healing.

Follow Medication Schedule

Consistent treatment supports better outcomes.

Protect Eyes from Irritants

Avoid exposure to smoke, dust, and pollutants.

Attend Follow-Up Appointments

Regular monitoring helps evaluate healing progress.

 

Why Choose CIPVISION GIVOSIRUN?

CIPVISION GIVOSIRUN combines advanced antiviral therapy with a patient-friendly ophthalmic gel formulation to support effective management of ocular viral infections.

Key Features:

• Contains Ganciclovir Ophthalmic Gel 0.15% w/w
• Effective antiviral action
• Supports corneal healing
• Prolonged ocular surface contact
• Helps manage herpes simplex keratitis
• Trusted ophthalmic formulation
• Designed for targeted ocular therapy

Conclusion

CIPVISION GIVOSIRUN (Ganciclovir Ophthalmic Gel 0.15% w/w) is an advanced antiviral eye care solution developed for the treatment of selected viral ocular infections, including herpes simplex keratitis. By inhibiting viral replication and supporting corneal healing, it helps protect eye health, improve patient comfort, and reduce the risk of complications.

With its sustained-release gel formulation and targeted antiviral action, CIPVISION GIVOSIRUN offers a reliable and effective option for ophthalmologists and patients seeking specialized management of viral eye infections.